Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 44 checked references that resolve
resolves10.1016/S1074-7613(02)00324-2IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naive CD4+ T Cells
resolves10.1038/nri1648New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions
resolves10.1038/nri1001Interleukin-12 and the regulation of innate resistance and adaptive immunity
resolves10.1038/nature01355Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
resolves10.1172/JCI21404IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
resolves10.1016/S0002-9394(00)00659-0Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
resolves10.1073/pnas.96.13.7462Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial
resolves10.1189/jlb.0305130Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis
resolves10.1084/jem.189.2.219Interleukin 12 Protects from a T Helper Type 1–mediated Autoimmune Disease, Experimental Autoimmune Uveitis, through a Mechanism Involving Interferon γ, Nitric Oxide, and Apoptosis
resolves10.4049/jimmunol.157.6.2668Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response
resolves10.4049/jimmunol.176.9.5652STAT3 and NF-κB Signal Pathway Is Required for IL-23-Mediated IL-17 Production in Spontaneous Arthritis Animal Model IL-1 Receptor Antagonist-Deficient Mice
resolves10.1073/pnas.1035999100IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist
resolves10.4049/jimmunol.173.2.737Cell Proliferation and STAT6 Pathways Are Negatively Regulated in T Cells by STAT1 and Suppressors of Cytokine Signaling
resolves10.4049/jimmunol.168.7.3181Suppressors of Cytokine Signaling Proteins Are Differentially Expressed in Th1 and Th2 Cells: Implications for Th Cell Lineage Commitment and Maintenance
resolves10.1038/ni1376Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system
resolves10.1016/j.jneuroim.2005.07.021Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): Potential neuroprotective role of SOCS proteins
resolves10.4049/jimmunol.140.5.1490A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
resolves10.1038/ni1375Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells
resolves10.4049/jimmunol.177.8.5377Two-Sided Roles of IL-27: Induction of Th1 Differentiation on Naive CD4+ T Cells versus Suppression of Proinflammatory Cytokine Production Including IL-23-Induced IL-17 on Activated CD4+ T Cells Partially Through STAT3-Dependent Mechanism
resolves10.4049/jimmunol.160.7.3513IL-17 Stimulates the Production and Expression of Proinflammatory Cytokines, IL-β and TNF-α, by Human Macrophages
resolves10.1084/jem.20060522Helper T cell differentiation enters a new era: Le Roi est mort; vive le Roi!
resolves10.1016/j.jns.2004.12.013IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis
resolves10.1016/j.jneuroim.2003.08.040Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases
resolves10.1007/s00347-003-0927-7Augenbeteiligung bei Morbus Beh�et: Erste 5-Jahres-Ergebnisse zur Visusentwicklung nach Therapie mit Interferon alfa-2a
resolves10.1136/ard.62.5.492Effects of interferon α treatment on the clinical course of refractory Behçet's disease: an open study
resolves10.1016/S0896-8411(03)00113-6Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration
resolves10.1016/j.jaut.2004.11.006SOCS5 mRNA levels in peripheral blood mononuclear cells (PBMC): a potential bio-marker for monitoring response of uveitis patients to Daclizumab therapy
The 2 references without a DOI — listed, not checked
no DOI — not checkedBecker, M.D., Garman, K., Whitcup, S.M., Planck, S.R. & Rosenbaum, J.T. Inhibition of leukocyte sticking and infiltration, but not rolling, by antibodies to ICAM-1 and LFA-1 in murine endotoxin-induced uveitis. Invest. Ophthalmol. Vis. Sci. 42, 2563–2566 (2001).
no DOI — not checkedNussenblatt, R.B. Proctor lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Invest. Ophthalmol. Vis. Sci. 32, 3131–3141 (1991).
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.